CoronaVac Vaccine Approved for Emergency Use to Vaccinate High-Risk Groups - Details Here! 

Home > News Shots > World news
By |

As countries are rushing with COVID-19 vaccine trials across the world, Sinovac Biotech Ltd's coronavirus vaccine candidate CoronaVac has been approved for emergency use in China. 

CoronaVac Vaccine Approved for Emergency Use to Vaccinate High-Risk Groups - Details Here! 

According to a Times Now report, this vaccine has been approved as part of a programme to vaccinate high-risk groups such as medical staff, a person familiar with the matter said.

Meanwhile, China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), has two vaccine candidates in phase 3 clinical trials. But they did not confirm which of its vaccines had been cleared for emergency use. 

However, China has been giving experimental coronavirus vaccines to high-risk groups since July, a health official told state media. So far, China has given little details on which vaccine candidates have been given to high-risk people under the emergency use programme. 

Currently, seven vaccines against the deadly COVID-19 are in final trial stages around the world, and four of them are from China, Times Now further reported. 

அரசியல், விளையாட்டு, நாட்டுநடப்பு, குற்ற சம்பவங்கள், வர்த்தகம், தொழில்நுட்பம், சினிமா, வாழ்க்கை முறை என பலதரப்பட்ட சுவாரஸ்யமான செய்திகளை தமிழில் படிக்க இங்கு கிளிக் செய்யவும்      

OTHER NEWS SHOTS